1. Landis SH,
Wurray T,
Bolden S,
et al.
Cancer statistics 1999.
Cancer J Clin 1999; 49: 8_31.
2. James SL,
Davies AM.
Postoperative imaging of soft tissue sarcomas.
Cancer Imaging.
2008 Feb 27;8:818.
doi: 10.1102/14707330.2008.0003.
Review.
PubMed
PMID: 18331968; PubMed Central PMCID: PMC2267691.
3. Potter DA,
Glenn J,
Kinsella T,
et al.
Patterns of recurrence in patients with highgrade soft tissue sarcomas.
J Clin Oncol 1985;3: 353_66.
4. Lewis JJ,
Leung D,
Heslin M,
et al.
Association of local recurrence with subsequent survival in extremity soft tissue sarcoma.
J Clin Oncol 1997; 15: 646_52.
5. Cormier JN,
Pollock RE.
Soft tissue sarcomas.
Cancer J Clin 2004; 54: 94_109.
6. Garner HW,
Kransdorf MJ,
Bancroft LW,
Peterson JJ,
Berquist TH,
Murphey MD.
Benign and malignant softtissue tumors: posttreatment MR imaging.
RadioGraphics
2009; 29(1):119–134.
7. Khoo MM,
Tyler PA,
Saifuddin A,
Padhani AR.
Diffusionweighted imaging (DWI) in musculoskeletal MRI: a critical review.
Skeletal Radiol 2011;40(6):665–681.
8. Koh DM,
Collins DJ.
Diffusionweighted MRI in the body: applications and challenges in oncology.
AJR Am J Roentgenol.
2007 Jun;188(6):162235.
Review.
PubMed PMID: 17515386.
9. Panicek DM,
Schwartz LH,
Heelan RT,
Caravelli JF.
Nonneoplastic causes of high signal intensity at T2 weighted MR imaging after treatment for musculoskeletal neoplasm.
Skeletal Radiol 1995;24:185190
10. Vanel D,
Shapeero LG,
De Baere T,
et al.
MR imaging in the follow up of malignant and aggressive soft tissue tumors: results of 511 examinations.
Radiology 1994; 190:
263_68.
11. Vanel D,
Lacombe MJ,
Couanet D,
et al.
Musculoskeletal tumors: follow up with MR imaging after treatment with surgery and radiation therapy.
Radiology 1987; 164: 243.
12. Shapeero LG,
Vanel D.
MR imaging in the followup evaluation of aggressive soft tissue tumors.
Semin Musculoskelet Radiol 1999; 3: 197_205.
13. Biondetti PR,
Ehman RL.
Soft tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging.
Radiology 1992; 183: 845_8.
14. Shapeero LG,
Vanel D,
Verstraete KL,
et al.
Dynamic contrast enhanced MR imaging for soft tissue sarcomas.
Semin Musculoskelet Radiol 1999; 3: 101_13.
15. Einarsdottir H,
Soderlund V,
Skoog L,
et al.
Dynamic MRI and fine needle aspiration cytology in the evaluation of soft tissue lesions.
Skeletal Radiol 2003; 32: 695_700.
16. Peterson KK,
Renfrew DL,
Feddersen RM,
et al.
Magnetic resonance imaging of myxoid containing tumors.
Skeletal Radiol 1991; 20: 245_50.
17. Davies AM,
Vanel D.
Followup of musculoskeletal tumors.
Eur Radiol 1998; 8: 791_9.
18. Del Grande F,
Subhawong T,
Weber K,
Aro M,
Mugera C,
Fayad LM.
Detection of softtissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T.
Radiology.
2014 May;271(2):499511.
19. Baur A,
Huber A,
Arbogast S,
et al.
Diffusion weighted imaging of tumor recurrencies and posttherapeutical softtissue changes in humans.
Eur Radiol 2001;11(5): 828–833.
20. Fayad LM,
Jacobs MA,
Wang X,
Carrino JA,
Bluemke DA.
Musculoskeletal tumors: how to use anatomic,
functional,
and metabolic MR techniques.
Radiology.
2012 Nov;265(2):34056.
21. Einarsdóttir H,
Karlsson M,
Wejde J,
Bauer HC.
Diffusionweighted MRI of soft tissue tumours.
Eur Radiol 2004;14(6):959–963.
22. Chenevert TL,
Meyer CR,
Moffat BA,
et al.
Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.
Mol Imaging 2002;1(4):336–343.
23. Subhawong TK,
Jacobs MA,
Fayad LM.
Diffusionweighted MR imaging for characterizing musculoskeletal lesions.
Radiographics.
2014 SepOct;34(5):116377.
24. Subhawong TK,
Jacobs MA,
Fayad LM.
Insights into quantitative diffusionweighted
MRI for musculoskeletal tumor imaging.
AJR Am J Roentgenol.
2014